TXN2

From Wikipedia, the free encyclopedia


Thioredoxin 2
PDB rendering based on 1uvz.
Available structures: 1uvz, 1w4v, 1w89
Identifiers
Symbol(s) TXN2; TRX2; MT-TRX; MTRX
External IDs OMIM: 609063 MGI1929468 HomoloGene40849
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 25828 56551
Ensembl ENSG00000100348 ENSMUSG00000005354
Uniprot Q99757 P97493
Refseq NM_012473 (mRNA)
NP_036605 (protein)
NM_019913 (mRNA)
NP_064297 (protein)
Location Chr 22: 35.19 - 35.21 Mb Chr 15: 77.74 - 77.76 Mb
Pubmed search [1] [2]

Thioredoxin 2, also known as TXN2, is a human gene.[1]

This nuclear gene encodes a mitochondrial member of the thioredoxin family, a group of small multifunctional redox-active proteins. The encoded protein may play important roles in the regulation of the mitochondrial membrane potential and in protection against oxidant-induced apoptosis.[1]

[edit] References

[edit] Further reading

  • Wang Z, Zhang H, Li XF, Le XC (2007). "Study of interactions between arsenicals and thioredoxins (human and E. coli) using mass spectrometry.". Rapid Commun. Mass Spectrom. 21 (22): 3658–66. doi:10.1002/rcm.3263. PMID 17939155. 
  • Udler M, Maia AT, Cebrian A, et al. (2007). "Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.". J. Clin. Oncol. 25 (21): 3015–23. doi:10.1200/JCO.2006.10.0099. PMID 17634480. 
  • Zhang H, Go YM, Jones DP (2007). "Mitochondrial thioredoxin-2/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress.". Arch. Biochem. Biophys. 465 (1): 119–26. doi:10.1016/j.abb.2007.05.001. PMID 17548047. 
  • Zhou J, Damdimopoulos AE, Spyrou G, Brüne B (2007). "Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1alpha.". J. Biol. Chem. 282 (10): 7482–90. doi:10.1074/jbc.M608289200. PMID 17220299. 
  • Oestergaard MZ, Tyrer J, Cebrian A, et al. (2006). "Interactions between genes involved in the antioxidant defence system and breast cancer risk.". Br. J. Cancer 95 (4): 525–31. doi:10.1038/sj.bjc.6603272. PMID 16868544. 
  • Cebrian A, Pharoah PD, Ahmed S, et al. (2006). "Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.". Cancer Res. 66 (2): 1225–33. doi:10.1158/0008-5472.CAN-05-1857. PMID 16424062. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Collins JE, Wright CL, Edwards CA, et al. (2005). "A genome annotation-driven approach to cloning the human ORFeome.". Genome Biol. 5 (10): R84. doi:10.1186/gb-2004-5-10-r84. PMID 15461802. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Damdimopoulos AE, Miranda-Vizuete A, Pelto-Huikko M, et al. (2002). "Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death.". J. Biol. Chem. 277 (36): 33249–57. doi:10.1074/jbc.M203036200. PMID 12080052. 
  • Chen Y, Cai J, Murphy TJ, Jones DP (2002). "Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells.". J. Biol. Chem. 277 (36): 33242–8. doi:10.1074/jbc.M202026200. PMID 12032145. 
  • Dunham I, Shimizu N, Roe BA, et al. (1999). "The DNA sequence of human chromosome 22.". Nature 402 (6761): 489–95. doi:10.1038/990031. PMID 10591208. 
  • Spyrou G, Enmark E, Miranda-Vizuete A, Gustafsson J (1997). "Cloning and expression of a novel mammalian thioredoxin.". J. Biol. Chem. 272 (5): 2936–41. PMID 9006939.